None listed
Conditions
Interventions
Intervention1: R For Rabbit Biomimic Head-to-Toe Wash: Manufactured by: VIKAS LABORATORIES PRIVATE LIMITED
Marketed by: R For Rabbit Baby Products Pvt Ltd
Route of administration: Topical
Mode of us
Sponsors
R For Rabbit Baby Products Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1.Gender: Male and Female 2.Age: 0 to 36 months (both inclusive). 3.Participant in good general health as determined by the Investigator on the basis of medical history. 4.Parent(s)or legally acceptable representative(s) willing to comply with study procedures and provide written informed consent as per regulatory requirements. 5.Not to use any other marketed product on application site during the study period.
Exclusion criteria
Exclusion criteria: 1.Participant has any known allergy to test product ingredient. 2.Participant has had any chronic disease or illness in the past three months or any clinically significant on-going chronic medical illness e.g. Congenital heart disease, Congestive heart failure, Hepatitis, Hypotensive episodes, etc. 3.Participant has participation in any similar consumer study within the past 90 days. 4.Participant is currently using any topical medications.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) To evaluate the safety of test products by assessing the change in local skin intolerance (skin dryness, irritation, redness, scaling) by Paediatrician and/or Paediatrician Trained Evaluation. 2) To evaluate the safety of the test products by assessing change in skin pH using pH meter 3) To evaluate the effect of the Biomimic Face Cream by assessing change in skin hydration level using Corneometer CM 825 4) To evaluate the safety of the test products in terms of Product Perception Questionnaire by Participant s mother s/ Caregiver feedback using a 5-point Likert scaleTimepoint: 1) from baseline before test product usage on Day 01 and after usage of test products on Day 15. 2) from baseline before test product usage on Day 01 and after usage of test products on Day 15. 3) from baseline before test product usage on Day 01 and after usage of test products on Day 02 and Day 15 ( 2 Days). 4) at Day 15 after product use | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NA | — |
Countries
India
Contacts
Public ContactDr Maheshvari Patel
NovoBliss Research Private Limited
Outcome results
None listed